114O Assessment of robotic versus laparoscopic distal gastrectomy for gastric cancer: A randomized controlled trial

Lu, Jianying; Wu, Dan; Hg, Wang; Zheng, Chao‐Hui; Li, P.; Xie, Jing; Jb, Wang; Lin, J-X.; Chen, Q-Y.; Cao, L-L.; Ma, Lin; Tu, Ru‐Hong; Huang, Zhixiong; Lin, J-L.; Zheng, Haowen; Changming, Huang

doi:10.1016/j.annonc.2020.10.135

Cited by 22 publications

(69 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Titles and abstracts were evaluated, and duplicate records were excluded. Full texts with relative bibliographies were thus appraised, and a total of 21 studies were eventually deemed suitable for inclusion and data extraction [ 4 , 5 , 6 , 8 , 13 , 15 , 17 , 18 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 ]. The selection process is given in Figure 1 , while Table 1 describes the general characteristics of the included studies.…”

Section: Resultsmentioning

confidence: 99%

“…Currently, the only available RCTs comparing LG and RG are those published by Pan et al [ 23 ] and Lu et al [ 24 ]. Some 163 patients who underwent MIG with curative intent for AGC were included in the trial published in 2017 by Pan et al RG was associated with significantly reduced blood losses and a higher number of yielded lymph nodes [ 23 ].…”

Section: Resultsmentioning

confidence: 99%

“…In the more recent trial by Lu et al, the authors compared the outcomes of patients receiving distal gastrectomy by surgeons with large expertise in MIG (>300 LG and 50 RG before trial initiation) [ 24 ]. In this trial, a total of 141 and 142 well-balanced patients were assigned to the RG group and the LG group, respectively.…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Review on Perioperative and Oncological Outcomes of Robotic Gastrectomy for Cancer

Giuliani

Guerra

Franco

et al. 2021

JPM

View full text Add to dashboard Cite

Background. Minimally invasive gastrectomy is currently considered a valid option to treat gastric cancer and is gaining increasing acceptance. Recent reports have suggested that the application of robots may confer some advantages over conventional laparoscopy, but the role of robotic surgery in clinical practice is still uncertain. We aimed to critically review the relevant evidence comparing robotic to standard laparoscopic surgery in performing radical gastrectomy. Methods. The Pubmed/Medline electronic databases were searched through February 2021. Paper conference and the English language was the only restriction applied to our search strategy. Results. According to the existing data, robotic gastrectomy seems to provide some benefits in terms of blood loss, rate of conversion, procedure-specific postoperative morbidity, and length of hospital stay. Robotic gastrectomy is also associated with a longer duration of surgery and a higher economic burden as compared to its laparoscopic counterpart. No significant differences have been disclosed in terms of long-term survivals, while the number of lymph nodes retrieved with robotic gastrectomy is generally higher than that of laparoscopy. Conclusions. The current literature suggests that robotic radical gastrectomy appears as competent as the conventional laparoscopic procedure and may provide some clinical advantages. However, due to the relative paucity of high-level evidence, it is not possible to draw definitive conclusions.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Review on Perioperative and Oncological Outcomes of Robotic Gastrectomy for Cancer

Giuliani

Guerra

Franco

et al. 2021

JPM

View full text Add to dashboard Cite

show abstract

“…Minimally invasive surgery, such as laparoscopic and robotic technique, has gained great popularity for its minimal trauma in the treatment of gastric cancer in these decades [3,[17][18][19]. However, laparoscopic surgery is lack of obtaining the three-dimensional anatomical vision and distinguishing relationship between intra-abdominal organs and vessels in spatial conformation compared with open surgery.…”

Section: Discussionmentioning

confidence: 99%

Effect of Preoperative CT Angiography Examination on the Clinical Outcome of Patients With BMI≥25.0kg/m2 Undergoing Laparoscopic Gastrectomy: Study Protocol for a Multicenter Randomized Controlled Trial

Meng

Cao

Liu

et al. 2021

Preprint

View full text Add to dashboard Cite

Background Gastric cancer, which ranks the fifth most common malignant and causes the third oncological death, especially in east Asian countries, such as China, Japan and Korea, is still a serious global healthy issue that caused heavy financial burden for the government and family. To our knowledge, there is seldom reports of multicenter randomized control trial on the utilization of CT angiography (CTA)for the patients who are diagnosed histological gastric cancer before surgery. Therefore, we conduct this RCT to verify whether the utilization of CTA can possibly change the short- and long-term clinical outcome or not. Method: The GISSG 20 − 01 study is a multicenter, prospective, open-lable clinical study that emphasis on the application of the CTA for the patients who will undergo the laparoscopic gastrectomy to prove the clinical outcome of it. 382 patients that meet the inclusion criteria and not in accordance with exclusion criteria will be recruited in the study and randomly divided into two groups with a 1:1 ratio: CTA group(n = 191) and Non-CTA group (n = 191). Apart from both of the two groups receive the examination of upper abdomen enhanced CT, the CTA group receive the examination of CT angiography. The primary endpoint of this trial is the volume of blood loss, the second primary endpoints are retrieved number of lymph nodes, postoperative recovery course, hospitalization costs, length of hospitalization days, postoperative complications, 3 years OS and 3 years DFS. Discussion It is anticipated that the result of this trial can provide high-level evidence and have clinical value on the application of CTA in laparoscopic gastrectomy. Trial registration: ClinicalTrials.gov, NCT04636099, Registered November 19, 2020

show abstract

“…In 2000, the U.S. Food and Drug Administration (FDA) approved the da Vinci Surgical System (DVSS) for clinical use, but due to its expensive equipment and high technical requirements, the clinical rollout has been slow and robotic gastrectomy. The use of robotic gastrectomy (RG) for the treatment of gastric cancer has been studied for more than a decade, and there is a lack of evidence that it can be used as a standard of care [22][23][24]. Gastric cancer surgeons expect the use of RG to overcome some of the disadvantages of conventional laparoscopic gastrectomy (LG) and to improve its safety, repeatability, and long-term outcome.…”

Section: The Development and Trend Of Minimally Invasive Surgery Of Gmentioning

confidence: 99%

Progress of Gastric Cancer Surgery in the era of Precision Medicine

et al. 2021

View full text Add to dashboard Cite

With the development of genomics, the update of modern imaging technology and the advent of artificial intelligence and big data, the surgical treatment of gastric cancer has gradually stepped into precision medicine. Precision surgery treatment of gastric cancer is based on accurate molecular typing and staging using modern molecular diagnostic technology and imaging, and the formulation of precise and individualized surgical treatment plans, with the concept of minimally invasive and accelerated rehabilitation surgery running through it. For intermediate-stage gastric cancer, we have adopted a comprehensive treatment approach including traditional radiotherapy and chemotherapy, targeted therapy and immunotherapy. Utilize artificial intelligence and big data technology to improve the standardization and interconnectivity of specialty data and realize the transformation of evidence-based medicine. Promoting the standardization, standardization and individualization of gastric cancer surgical treatment, providing patients with precise diagnosis and treatment, and further improving patients' prognosis are the opportunities and challenges in the development of gastric cancer surgery.

show abstract

114O Assessment of robotic versus laparoscopic distal gastrectomy for gastric cancer: A randomized controlled trial

Cited by 22 publications

References 0 publications

Review on Perioperative and Oncological Outcomes of Robotic Gastrectomy for Cancer

Review on Perioperative and Oncological Outcomes of Robotic Gastrectomy for Cancer

Effect of Preoperative CT Angiography Examination on the Clinical Outcome of Patients With BMI≥25.0kg/m2 Undergoing Laparoscopic Gastrectomy: Study Protocol for a Multicenter Randomized Controlled Trial

Progress of Gastric Cancer Surgery in the era of Precision Medicine

Contact Info

Product

Resources

About